ClinicalTrials.gov
public full text
Public Domain
Alzheimer's Disease THErapy With NEuroaid II
ATHENE II is a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial designed to evaluate the efficacy and safety of MLC901 in subjects with mild to moderate Alzheimer's disease, as well as its effects on plasma biomarkers compared to placebo.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Phase 2 Study to Evaluate the Safety and Efficacy of BEY2153 in Patients with Early Alzheimer's Disease#1309276
- Study to Test Effects and Safety of RO7568282 in Early Symptomatic Alzheimer's Disease#1072862
- ATH-1017 for Treatment of Mild to Moderate Alzheimer's Disease#866669
- Bryostatin Treatment of Moderately Severe Alzheimer's Disease#900385
- A Study of LY3372993 in Healthy Participants and Participants With Alzheimer's Disease (AD)#1369190
Record · ID 1295837
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive